LACTOSE-FREE, NON-HYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL COMPOSITIONS OF DESCARBOETHOXYLORATADINE

Stable pharmaceutical compositions of descarboethoxyloratadine (DCL), a metabolic derivative of loratadine, for the treatment of allergic rhinitis and other histamine-induced disorders are disclosed. The compositions are formulated to avoid the incompatibility between DCL and reactive excipients suc...

Full description

Saved in:
Bibliographic Details
Main Authors WALD, STEPHEN, A, REDMON, MARTIN, P, RUBIN, PAUL, D, BUTLER, HAL, T
Format Patent
LanguageEnglish
French
Published 13.08.1998
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Stable pharmaceutical compositions of descarboethoxyloratadine (DCL), a metabolic derivative of loratadine, for the treatment of allergic rhinitis and other histamine-induced disorders are disclosed. The compositions are formulated to avoid the incompatibility between DCL and reactive excipients such as lactose and other mono- and di-saccharides. Disclosed compositions include lactose-free, non-hygroscopic and anhydrous stable pharmaceutical compositions of DCL. La présente invention a trait à des compositions pharmaceutiques stables de descarboéthoxyloratadine (DLC) qui est un dérivé métabolique de la loratadine, destinées au traitement de la rhinite allergique et d'autres troubles engendrés par l'histamine. Les compositions sont formulées de manière à éviter l'incompatibilité entre le DCL et les excipients réactifs tels que le lactose, et d'autres monosaccharides et disaccharides. Les compositions de cette invention renferment des compositions pharmaceutiques de DCL exemptes de lactose, non hygroscopiques, anhydres et stables.
Bibliography:Application Number: WO1998US02328